News

Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.
The ASO for myotonic dystrophy type 1 was well tolerated and improved splicing and function in a study presented at ASGCT.
“This is the first step towards the use of gene editing therapies to treat a wide variety of rare genetic disorders for which ...
Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...
Obsessive compulsive disorder has many unknowns, including what causes it, why symptoms can differ so much between people, ...
At the Cardiff School of Medicine, PhD students are working to catch bowel cancer as soon as possible. By identifying genes linked to the condition, they are collecting vital new data on key risk ...
Ferroptosis-related genes including driver genes, suppressor genes, marker genes, and unclassified genes were ... and that of the internal control gene Beta-actin in each sample was calculated as ΔCT ...
In the model plant Arabidopsis thaliana, the transition from seed to seedling involves turning off a specific set of genes that are ... eukaryotic epigenetic marker added by PRC2.